1. Home
  2. FMS vs NCLH Comparison

FMS vs NCLH Comparison

Compare FMS & NCLH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FMS
  • NCLH
  • Stock Information
  • Founded
  • FMS 1996
  • NCLH 1966
  • Country
  • FMS Germany
  • NCLH United States
  • Employees
  • FMS N/A
  • NCLH N/A
  • Industry
  • FMS Misc Health and Biotechnology Services
  • NCLH Marine Transportation
  • Sector
  • FMS Health Care
  • NCLH Consumer Discretionary
  • Exchange
  • FMS Nasdaq
  • NCLH Nasdaq
  • Market Cap
  • FMS 13.4B
  • NCLH 12.1B
  • IPO Year
  • FMS 1996
  • NCLH 2013
  • Fundamental
  • Price
  • FMS $24.64
  • NCLH $25.68
  • Analyst Decision
  • FMS Hold
  • NCLH Buy
  • Analyst Count
  • FMS 1
  • NCLH 16
  • Target Price
  • FMS $25.00
  • NCLH $29.27
  • AVG Volume (30 Days)
  • FMS 213.3K
  • NCLH 7.4M
  • Earning Date
  • FMS 02-25-2025
  • NCLH 02-25-2025
  • Dividend Yield
  • FMS 2.58%
  • NCLH N/A
  • EPS Growth
  • FMS 46.47
  • NCLH N/A
  • EPS
  • FMS 2.50
  • NCLH 1.25
  • Revenue
  • FMS $21,457,738,113.00
  • NCLH $9,356,741,000.00
  • Revenue This Year
  • FMS N/A
  • NCLH $13.11
  • Revenue Next Year
  • FMS $3.88
  • NCLH $8.08
  • P/E Ratio
  • FMS $19.37
  • NCLH $20.54
  • Revenue Growth
  • FMS N/A
  • NCLH 15.76
  • 52 Week Low
  • FMS $17.93
  • NCLH $14.69
  • 52 Week High
  • FMS $24.67
  • NCLH $28.64
  • Technical
  • Relative Strength Index (RSI)
  • FMS 72.34
  • NCLH 45.28
  • Support Level
  • FMS $22.90
  • NCLH $25.82
  • Resistance Level
  • FMS $23.27
  • NCLH $28.13
  • Average True Range (ATR)
  • FMS 0.29
  • NCLH 0.90
  • MACD
  • FMS 0.18
  • NCLH 0.03
  • Stochastic Oscillator
  • FMS 98.66
  • NCLH 32.88

About FMS Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.

About NCLH Norwegian Cruise Line Holdings Ltd.

Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 66,500). It operates 32 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 13 passenger vessels on order among its brands through 2036, representing 41,000 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.

Share on Social Networks: